LAB vs DCTH
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 25, 2026
LAB
49.6
AI Score
VS
DCTH Wins
DCTH
60.3
AI Score
Investment Advisor Scores
DCTH
60score
Recommendation
BUY
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | LAB | DCTH | Winner |
|---|---|---|---|
| Revenue | 41.25M | 54.13M | DCTH |
| Net Income | 100.31M | 1.60M | LAB |
| Gross Margin | 53.0% | 87.6% | DCTH |
| Net Margin | 243.2% | 3.0% | LAB |
| Operating Income | -37.88M | 758,000 | DCTH |
| ROE | 18.6% | 1.3% | LAB |
| ROA | 16.0% | 1.2% | LAB |
| Total Assets | 627.22M | 137.02M | LAB |
| Cash | 270.03M | 47.52M | LAB |
| Current Ratio | 9.10 | 9.83 | DCTH |
| Free Cash Flow | -57.82M | 5.50M | DCTH |
Relative Price Performance (Last 90 Days)
LAB 1M: -18.5%
· 3M: -21.8%
DCTH 1M: -10.3%
· 3M: +20.8%
Current Technical Phase
LAB
MarkdownSell / avoid
Price below a falling SMA50 (slope -8.0%), weak momentum, RSI 36
DCTH
NeutralHold
Mixed signals - no dominant trend phase, RSI 40
Fundamentals Snapshot
| Metric | LAB | DCTH |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -3.8 | 320.4 |
| Trailing P/E | — | 1475.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.2% |
| Gross Margin | 0.5% | 0.9% |
| Operating Margin | -0.4% | 0.1% |
| EPS | -0.13 | 0.01 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, DCTH is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.